Anti-SV40T [PAb419]
Invented at Cancer Research UK London Research Institute: Clare Hall Laboratories
- Datasheet
- References (4)
- Inventor Info
Info
Catalogue Number | 153337 |
Applications | IF IP WB |
Antigen/Gene or Protein Targets | N-terminal domain of SV40 large and small T-antigen |
Reactivity | Virus |
Relevance | SV40 is a simian oncogenic polyoma virus. The SV40 large T antigen is an early protein that interacts with the p53 and Rb tumour suppressor proteins. |
Host | Mouse |
Immunogen | SV40 large and small T-antigen |
Positive Control | SV40 infected cells |
Subclass | IgG2a |
Molecular Weight (kDa) | 94 |
Recommended Growing Conditions | DMEM 5% FCS |
Notes |
Western blotting Immunofluorescence (1-5 µg/ml) Immunoprecipitation (1-2 µg/sample) |
Research Area | Virology |
References: 4 entries
Goolsby et al. 1991. Cytometry. 12(8):748-56. PMID: 1665408.
Viral and cellular oncogene expression during progressive malignant transformation of SV40 transformed human fibroblasts.
Europe PMC ID: 1665408
Monoclonal antibodies specific for simian virus 40 tumor antigens.
Europe PMC ID: 6169844
Harlow et al. 1981. J Virol. 39(3):861-9. PMID: 6169844.
Add a reference
References: 4 entries
Goolsby et al. 1991. Cytometry. 12(8):748-56. PMID: 1665408.
Viral and cellular oncogene expression during progressive malignant transformation of SV40 transformed human fibroblasts.
Monoclonal antibodies specific for simian virus 40 tumor antigens.
Harlow et al. 1981. J Virol. 39(3):861-9. PMID: 6169844.
Add a reference